Published online Aug 25, 2016. doi: 10.4253/wjge.v8.i16.558
Peer-review started: April 6, 2016
First decision: May 17, 2016
Revised: June 7, 2016
Accepted: July 11, 2016
Article in press: July 13, 2016
Published online: August 25, 2016
Processing time: 142 Days and 17.1 Hours
To clarify the diagnostic efficacy and limitations of endoscopic ultrasonography (EUS) and the characteristics of early gastric cancers (EGCs) that are indications for EUS-based assessment of cancer invasion depth.
We retrospectively investigated the cases of 153 EGC patients who underwent conventional endoscopy (CE) and EUS (20 MHz) before treatment.
We found that 13.7% were “inconclusive” cases with low-quality EUS images, including all nine of the cases with protruded (0-I)-type EGCs. There was no significant difference in the diagnostic accuracy between CE and EUS. Two significant independent risk factors for misdiagnosis by EUS were identified-ulcer scarring [UL(+); odds ratio (OR) = 4.49, P = 0.003] and non-indication criteria for endoscopic resection (ER) (OR = 3.02, P = 0.03). In the subgroup analysis, 23.1% of the differentiated-type cancers exhibiting SM massive invasion (SM2) invasion (submucosal invasion ≥ 500 μm) by CE were correctly diagnosed by EUS, and 23.1% of the undifferentiated-type EGCs meeting the expanded-indication criteria for ER were correctly diagnosed by EUS.
There is no need to perform EUS for UL(+) EGCs or 0-I-type EGCs, but EUS may enhance the pretreatment staging of differentiated-type EGCs with SM2 invasion without UL or undifferentiated-type EGCs revealed by CE as meeting the expanded-indication criteria for ER.
Core tip: With the increasingly expanded indications of endoscopic resection for early gastric cancer (EGC), the accurate diagnosis of the invasion depth has become more important in the pretreatment strategy. Although there have been many investigations comparing the efficacy of endoscopic ultrasonography (EUS) and conventional endoscopy (CE) for invasion depth diagnosis of EGCs, much controversy remains. Our results revealed that there is no need to perform EUS for EGCs that are protruded type or those that have an ulcer scar, but EUS may have an add-on effect in the pretreatment staging of differentiated-type EGCs diagnosed as SM2 (submucosal invasion ≥ 500 μm) and undifferentiated-type EGCs diagnosed by CE as meeting the expanded-indication criteria for endoscopic resection.
